Huntsville, Ala. – The HudsonAlpha Clinical Services Lab (CSL) announced today it has received re-certification from the College of American Pathologists (CAP), ensuring the lab has continued to meet and exceed industry standards for clinical laboratory testing.
CAP accredits laboratories performing testing on specimens from human beings or animals, using methodologies and clinical application within the expertise of the program. Laboratories must be appropriately licensed to perform testing when required by law.
“The CSL is committed to providing genomic data and analysis to physicians, healthcare institutions and patients,” said Elaine Lyon, PhD, FACMG, director of the CSL. “CAP accreditation allows us to continue our mission to improve health through diagnostic and preventive care.”
The U.S. federal government recognizes the CAP Laboratory Accreditation Program as being equal-to or more-stringent-than the government’s own inspection program. During the CAP accreditation process, inspectors examine the laboratory’s records and quality control of procedures for the preceding two years. CAP inspectors also examine laboratory staff qualifications, equipment, facilities, safety program and record, and overall management.
“This is an important achievement for clinical laboratories and HudsonAlpha is proud to be home to one of the 8,000 CAP-accredited facilities in the world,” said Rick Myers, PhD, HudsonAlpha president and science director.
The CSL was established in 2014 to advance the application of genomic technologies in clinical research and diagnostics. The lab is one of only two dozen clinical laboratories providing whole genome sequencing and analysis, and is developing a number of new genetic and genomic clinical tests. To learn more about the CSL, visit http://clinicallab.org.
About HudsonAlpha: HudsonAlpha Institute for Biotechnology is a nonprofit institute dedicated to developing and applying scientific advances to health, agriculture, learning, and commercialization. Opened in 2008, HudsonAlpha’s vision is to leverage the synergy between discovery, education, medicine, and economic development in genomic sciences to improve the human condition around the globe. The HudsonAlpha biotechnology campus consists of 152 acres nestled within Cummings Research Park, the nation’s second largest research park. The state-of-the-art facilities co-locate nonprofit scientific researchers with entrepreneurs and educators. HudsonAlpha has become a national and international leader in genetics and genomics research and biotech education and fosters more than 40 diverse biotech companies on campus. To learn more about HudsonAlpha, visit hudsonalpha.org.
About the College of American Pathologists: As the world’s largest organization of board-certified pathologists and leading provider of laboratory accreditation and proficiency testing programs, the College of American Pathologists (CAP) serves patients, pathologists, and the public by fostering and advocating excellence in the practice of pathology and laboratory medicine worldwide. For more information, read the CAP Annual Report at cap.org.